Malcolm Hoffman
Analyst, BMO Capital Markets
Analyst — BMO Capital Markets
Analyst — BMO Capital Markets (on behalf of Evan Seigerman)
Analyst — BMO (on behalf of Evan Seigerman)
Earnings-call appearances
-
Q2 2026 Earnings Results and Business Update2026-08-05
AbCellera Biologics Inc. (ABCL)
-
AbbVie Inc. Q2 FY2026 Earnings Call2026-07-06
AbbVie Inc. (ABBV)
-
Acadia Pharmaceuticals Inc Q1 FY2026 Earnings Call2026-05-06
Acadia Pharmaceuticals Inc (ACAD)
-
AbCellera Biologics Inc. Q4 FY2025 Earnings Call2026-02-24
AbCellera Biologics Inc. (ABCL)
-
Bristol Myers Squibb Co Q4 FY2025 Earnings Call2026-02-05
Bristol Myers Squibb Co (BMY)
-
Acadia Pharmaceuticals Inc Q3 FY2025 Earnings Call2025-11-05
Acadia Pharmaceuticals Inc (ACAD)
-
BioNTech SE Q3 FY2025 Earnings Call2025-09-30
BioNTech SE (BNTX)
-
AbCellera Biologics Inc. Q2 FY2025 Earnings Call2025-08-07
AbCellera Biologics Inc. (ABCL)
-
Acadia Pharmaceuticals Inc Q2 FY2025 Earnings Call2025-08-06
Acadia Pharmaceuticals Inc (ACAD)
-
Taysha Gene Therapies, Inc. Q1 FY2025 Earnings Call2025-05-15
Taysha Gene Therapies, Inc. (TSHA)
-
Incyte Corp Q1 FY2025 Earnings Call2025-04-29
Incyte Corp (INCY)
-
Schrodinger, Inc. Q4 FY2024 Earnings Call2025-02-26
Schrodinger, Inc. (SDGR)
-
AbCellera Biologics Inc. Q3 FY2023 Earnings Call2023-11-02
AbCellera Biologics Inc. (ABCL)
-
Schrodinger, Inc. Q3 FY2023 Earnings Call2023-11-01
Schrodinger, Inc. (SDGR)
-
AbCellera Biologics Inc. Q1 FY2023 Earnings Call2023-05-04
AbCellera Biologics Inc. (ABCL)